Search research articles
Contact Us
Filters
Showing results (1-10 of 210) with videos related to
Page
of 21
Sort By:
Histopathology
|
January 26, 2011
Molecular cytogenetics of lymphoma: where do we stand in 2010?
Philip Kluin, Ed Schuuring
Molecular Oncology
|
February 5, 2020
The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction
Paul van der Leest, Ed Schuuring
Clinical Chemistry
|
January 4, 2024
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling
Paul van der Leest, Ed Schuuring
Diagnostics (Basel, Switzerland)
|
October 21, 2020
Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
Cleo Keppens, Ed Schuuring, Elisabeth Mc Dequeker
Virchows Archiv : an International Journal of Pathology
|
November 23, 2020
Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
Cleo Keppens, Ed Schuuring, Elisabeth M C Dequeker
Journal of the National Cancer Institute. Monographs
|
July 24, 2008
Structure and consequences of IGH switch breakpoints in Burkitt lymphoma
Jeroen E J Guikema, Ed Schuuring, Philip M Kluin
Lung Cancer (Amsterdam, Netherlands)
|
June 18, 2022
Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer
Hylke C Donker, Ed Schuuring, Ellen Heitzer, et al.
Experimental Cell Research
|
March 11, 2006
Cortactin affects cell migration by regulating intercellular adhesion and cell spreading
Agnes G S H van Rossum, Wouter H Moolenaar, Ed Schuuring
The Journal of Pathology
|
September 19, 2002
Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections
Eugenia Haralambieva, Karin Kleiverda, David Y Mason, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 17, 2011
[New 'targeted therapy' for lung cancer]
Harry J M Groen, Thijo J N Hiltermann, Ed Schuuring, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 210) with videos related to
Sort By:
Page
of 21
Histopathology
|
January 26, 2011
Molecular cytogenetics of lymphoma: where do we stand in 2010?
Philip Kluin, Ed Schuuring
Molecular Oncology
|
February 5, 2020
The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction
Paul van der Leest, Ed Schuuring
Clinical Chemistry
|
January 4, 2024
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling
Paul van der Leest, Ed Schuuring
Diagnostics (Basel, Switzerland)
|
October 21, 2020
Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
Cleo Keppens, Ed Schuuring, Elisabeth Mc Dequeker
Virchows Archiv : an International Journal of Pathology
|
November 23, 2020
Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
Cleo Keppens, Ed Schuuring, Elisabeth M C Dequeker
Journal of the National Cancer Institute. Monographs
|
July 24, 2008
Structure and consequences of IGH switch breakpoints in Burkitt lymphoma
Jeroen E J Guikema, Ed Schuuring, Philip M Kluin
Lung Cancer (Amsterdam, Netherlands)
|
June 18, 2022
Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer
Hylke C Donker, Ed Schuuring, Ellen Heitzer, et al.
Experimental Cell Research
|
March 11, 2006
Cortactin affects cell migration by regulating intercellular adhesion and cell spreading
Agnes G S H van Rossum, Wouter H Moolenaar, Ed Schuuring
The Journal of Pathology
|
September 19, 2002
Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections
Eugenia Haralambieva, Karin Kleiverda, David Y Mason, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 17, 2011
[New 'targeted therapy' for lung cancer]
Harry J M Groen, Thijo J N Hiltermann, Ed Schuuring, et al.
Page
of 21